Pharma-Grade Sodium Bicarbonate Market

Pharma Grade Sodium Bicarbonate Market Size Analysis

According to a recent survey conducted by ChemView Consulting, the Global Pharma Grade Sodium Bicarbonate Market grew at a CAGR of 4.1% between 2017-2021 and is estimated to be US$ 291.6Mn in 2022. Currently, the market is anticipated to grow at a CAGR of 4.7% and is expected to reach a valuation of US$ 461.6Mn by 2032 end.

One major element driving up sales in this market is the expanding use of generic sodium bicarbonate in topical cleaning solutions and systemic alkalizer syrups. It is also used as a pH buffering agent for replacing electrolytes.

Everywhere in the world, soda bicarbonate in pharmaceutical products has increased dramatically. It is widely utilized in this business as an excipient and an Active Pharmaceutical Ingredient (API) to treat conditions like metabolic acidosis, primary lactic acidosis, extracorporeal blood circulation, uncontrolled diabetes, and cardiac arrest.

Market Dynamic

THE USAGE OF SODIUM BICARBONATE POWDER IN TOOTHPASTE BOLSTERS THE MARKET

It is predicted that shortly, there will be an increase in the prevalence of several autoimmune disorders, including type 2 diabetes, rheumatoid arthritis, irritable bowel syndrome, atherosclerosis, and cardiovascular disease. Patients taking these drugs might aid in triggering an anti-inflammatory pathway and preventing autoimmune disorders.

Generic sodium bicarbonate is probably used as an ingredient by several personal care product manufacturers operating on a global scale to make toothpaste. In addition to speeding up, teeth whitening helps prevent gum disorders, cavities, and tooth decay. WHO estimates that almost 3.5 billion individuals worldwide suffer from oral disorders, with untreated tooth decay being the most prevalent illness affecting permanent teeth. During the forecast period, it is predicted that these factors will increase demand for sodium bicarbonate powder.

THE GROWING APPLICATION LANDSCAPE OF PHARMA GRADE SODIUM BICARBONATE MARKET MAY BRING IMMENSE GROWTH OPPORTUNITIES

The market for pharmaceutical-grade sodium bicarbonate is expanding, which may present tremendous potential opportunities. Some important uses of pharma-grade sodium bicarbonate include excipients, antacids, tablet coating, hemodialysis, API, toothpaste, and others. They come in fine and coarse grades.

The API market is predicted to keep a prominent position in terms of application. The development of effervescent pills and pharmaceutical-grade sodium bicarbonate as a manufacturing step are both common uses. The pharma-grade sodium bicarbonate market may benefit from these factors as growth catalysts.

Market Segments Covered in Report

By Application:

• API
• Excipients
• Antacids
• Haemodialysis
• Tablet Coating
• Toothpaste
• Others

By Grade:

• Fine
• Coarse

By Region and Country:

• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Europe (Germany, Italy, France, UK, Spain, Netherlands, Norway, Russia, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Indonesia, Thailand, Vietnam, Australia & New Zealand, Rest of Asia-Pacific)
• Middle East (Saudi Arabia, Turkey, UAE, Rest of Middle East)
• Africa (South Africa, Nigeria, Egypt, Rest of Africa)

Segment-Wise Analysis

Which is the leading application segment in the pharma-grade sodium bicarbonate market?

According to the application, the API sector is projected to hold around 32.5% of the global market for pharmaceutical-grade sodium bicarbonate. The increased use of APIs as an intermediary in producing numerous pharmaceutical medicines is responsible for this expansion.

Many businesses plan to use APIs in the manufacturing of effervescent tablets. Sales of soda bicarbonate are anticipated to increase due to the rising demand for performance-enhancing pharmaceuticals in both emerging and industrialized nations. Another important element that is expected to encourage the use of APIs is the urgent demand for small molecules, which are seen to be an essential component of prescription medications for secondary therapy prescribed by specialists.

Region-Wise Analysis

The regions analyzed for the market include North America, Europe, Latin America, Asia Pacific, Middle East, and Africa.

• With a market share of 52.6%, the Asia Pacific Region is expected to lead the world in the production of pharmaceutical-grade sodium bicarbonate because of the increasing public awareness of the accessibility of numerous over-the-counter treatments to cure acidity. Another factor driving the market in this nation is the rising prevalence of heartburn.
• The market for pharmaceutical-grade sodium bicarbonate in North America is anticipated to expand rapidly between 2023 and 2032. The rising research and development activities may be a significant growth factor in the area.

Competition Analysis

The main market participants for pharmaceutical-grade sodium bicarbonate are concentrating on introducing novel injection-based products for the global medical sector. To meet the increased demand from customers, they are also participating in partnerships, mergers, acquisitions, and joint ventures to market their products in different healthcare facilities. While this is going on, some other businesses are working diligently to introduce cutting-edge sodium bicarbonate treatments for various illnesses.

The key developments in the Global Pharma Grade Sodium Bicarbonate Market:

• In September 2019, Sodium Bicarbonate Injection, USP, was introduced by Exela Pharma Sciences, a rapidly expanding specialty pharmaceutical business with headquarters in the United States. To distribute these injections in hospitals, the company intends to collaborate with Premier and Civica Rx. The company wants to improve access to affordable medicines globally and stop drug shortages.
• In September 2019, Exela Pharma Sciences, a fast-growing specialty pharmaceutical company with its corporate headquarters in the United States, introduced Sodium Bicarbonate Injection, USP. The business also plans to partner with Premier and Civica Rx to distribute these injections in hospitals. The company seeks to end drug shortages and increase access to cheap medications worldwide.

A list of some of the key suppliers present in the market are:

• Solvay SA
• Tata Chemicals
• Novacarb (Novacap Group)
• Paul Lohmann GmbH KG
• GHCL Limited
• CIECH S.A.
• Natural Soda LLC
• Jost Chemical Co.
• Tronox Alkali Corporation

Report Coverage and Highlights

• Our comprehensive, data-backed, and facts-oriented report provides niche and cross-sectional analysis at global and country levels.
• Assessment of the historical (actual data) and current market size (2017-2021), market projections (2022-2032), and CAGR.
• The market assessment across North America, Europe, East Asia, South Asia & Pacific, Latin America, Middle East, and Africa.
• Competitive tactical intelligence, key strategies adopted by top players, production capacity and company shares analysis, product brand surveys, and export-import analysis
• Pricing analysis to set and benchmark your current or future offerings across each product type helps you understand whether your pricing strategy is aligned with market expectations and can be compared to market disruptions.
• Predictions on critical supply and demand trends and technological expertise needed to address operations scalability.
• Consumer behavior shifts and their implications for players, list of end-users, and their consumption analysis.
• Key drivers, restraints, opportunities, and emerging trends impacting the market growth.
• Value chain analysis (list of manufacturers, distributors, end-users, and average profitability margins).
• Strategic market analysis, recommendations, and future headways on crucial winning strategies.